Blueyard Capital

What they fund

• Stage: Pre-seed to Series B, with a heavy concentration on seed and inception rounds [1].
• Sector: Applied computation, defense systems, foundational bio/chem, and crypto infrastructure [1].
• Geography: Primarily EU and US, with a focus on high-impact, global technologies [1].
• Shape: Foundational, high-variance technologies that address existential threats or utopian goals [1].

Investment thesis

Blueyard Capital operates on a binary "Utopia vs. Oblivion" framework, investing exclusively in technologies that either advance utopian goals or defend against existential threats [1]. The firm targets high-impact variance, backing innovations critical to societal stability and technological breakthroughs rather than incremental improvements [1]. They focus on applied computation, engineering, aerospace & defense, biology & chemistry, and crypto [1]. Their thesis is driven by the belief that the margin for error is "deadly sharp" and the band of possible outcomes has widened [1].

Credibility: BlueYard Capital manifesto and homepage [1].

Value add

Blueyard Capital provides strategic partnerships, follow-on funding support, and access to a network of co-investors like Sequoia, Paradigm, and EQT [1]. They partner with founders at early stages, offering guidance on scaling and fundraising [1].

Fit verdict: Ideal for founders in deep tech, defense, and crypto seeking high-impact, long-term partners.

Founder diligence script:

• What is your strategy for navigating the "deadly sharp" margin for error in your sector?
• How do you plan to leverage Blueyard's network for follow-on funding?
• What are your key milestones for achieving utopian or defensive impact?
• How do you see Blueyard's thesis aligning with your long-term vision?
• What are your plans for scaling in the EU and US markets?

Portfolio focus

• Computation & Intelligence: Corintis, Filecoin, Privy, Groq, IonQ [1]
• Engineering, Aerospace & Defense: Castelion, Chemify, FreedomFi, ZeroPhase, Stark [1]
• Biology & Chemistry: bit.bio, Chemify, Transcripta Bio, Aerska, clock.bio [1]
• Crypto: Filecoin, Privy, Blockspace Forum, Decred [1]

Notable investments & exits

• Privy: Acquired by Stripe [1].
• FreedomFi: Acquired by Nova Labs [1].
• IonQ: IPO [1].
• Groq: Exit [1].
• Filecoin: $200m ICO + live network [1].

Strategic implications

Blueyard's "Utopia vs. Oblivion" thesis creates a moat in deep tech and defense, where high-variance outcomes are the norm. Their focus on applied computation and foundational bio/chem positions them to capture outsized returns in sectors with long development cycles. The main risk is the binary nature of the thesis, which may limit deal flow in adjacent sectors. A signal to change the read would be a shift towards later-stage or more incremental technologies.

Where they could go further

Blueyard could deepen its focus on climate tech, a sector that aligns with the "utopian" goal but is underrepresented in the current portfolio. Interconnection: This would diversify the portfolio while staying true to the core thesis. The firm could establish a dedicated defense tech fund, given the growing importance of aerospace & defense in the current geopolitical landscape. Interconnection: This would allow for more targeted investing and resource allocation. Blueyard could enhance its founder support by creating a dedicated program for scaling in the US market, given the firm's EU roots. Interconnection: This would help bridge the gap between EU and US ecosystems.